Octanoic Acid

Octanoic Acid

SCHEMBL3125481

CCCCCCCC(=O)[O-].CCCCn1cc[n+](C)c1

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.65
HSP90AA1 P07900 2/20 0.65
KMT2A Q03164 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
APAF1 O14727 1/20 0.65
NPC1 O15118 1/20 0.65
PLA2G1B P04054 1/20 0.65
MAPT P10636 1/20 0.65
MAPK1 P28482 1/20 0.65
HTT P42858 1/20 0.65
RAB9A P51151 1/20 0.65
NPSR1 Q6W5P4 1/20 0.65
ATG4B Q9Y4P1 1/20 0.65
FDPS P14324 12/20 0.44
FABP3 P05413 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dodecanoate SCHEMBL31549880 1.00 MEN1 (0.65) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Hexanoate SCHEMBL19406560 0.99 MEN1 (0.62) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Palmitic Acid SCHEMBL28783471 0.97 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Palmitic Acid SCHEMBL28783451 0.97 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Palmitic Acid SCHEMBL28783483 0.97 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Myristic Acid SCHEMBL28783491 0.97 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Myristic Acid SCHEMBL28783522 0.97 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Dodecanoate SCHEMBL28783503 0.97 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Myristic Acid SCHEMBL28783475 0.97 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Valeric Acid SCHEMBL446967 0.94 MEN1 (0.59) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12054578-B2 Process for producing porous materials AEROGEL-IT GMBH (DE) 2024-08-06 US disclosed
EP-3405509-B1 PROCESS FOR PRODUCING POROUS MATERIALS AEROGEL IT GMBH (DE) 2023-07-12 EP disclosed
CN-110914326-B Method for producing porous material 埃力格-伊特有限责任公司 2023-06-13 CN disclosed
CN-108473658-B Method for producing porous material 巴斯夫欧洲公司 2022-08-26 CN disclosed
US-20220098384-A1 Process for producing porous materials BASF SE (DE) 2022-03-31 US disclosed
US-11248101-B2 Process for producing porous materials BASF SE (DE) 2022-02-15 US disclosed
EP-3911694-A1 PROCESS FOR PRODUCING POROUS MATERIALS BASF SE (DE) 2021-11-24 EP disclosed
CN-113302232-A Method for producing porous material 巴斯夫欧洲公司 2021-08-24 CN disclosed
US-20210139662-A1 POROUS MATERIALS WITH SUPERIOR REVERSIBLE WATER UPTAKE BASF SE (DE) 2021-05-13 US disclosed
US-20210139633-A1 PROCESS FOR PRODUCING POROUS MATERIALS BASF SE (DE) 2021-05-13 US disclosed
US-20170088962-A1 CUSTOM IONIC LIQUID ELECTROLYTES FOR ELECTROLYTIC DECARBOXYLATION ENLIGHTEN INNOVATIONS INC. (CA) 2017-03-30 US disclosed
WO-2017050679-A1 PROCESS FOR PRODUCING POROUS MATERIALS BASF SE (DE) 2017-03-30 WO disclosed
EP-3122808-A1 PROCESS FOR PRODUCING POROUS MATERIALS BASF SE (DE) 2017-02-01 EP disclosed
US-9493882-B2 Custom ionic liquid electrolytes for electrolytic decarboxylation CERAMATEC, INC. (US) 2016-11-15 US disclosed
WO-2016150684-A1 PROCESS FOR PRODUCING POROUS MATERIALS COMPRISING A CATALYST SYSTEM BASF SE (DE) 2016-09-29 WO disclosed
US-20160254098-A1 METHOD FOR PREPARING IONIC LIQUID HAVING CARBOXYLIC ACID ANION USING MICROREACTOR CHEMTECH RESEARCH INCORPORATION (KR) 2016-09-01 US disclosed
WO-2015144698-A1 PROCESS FOR PRODUCING POROUS MATERIALS BASF SE (DE) 2015-10-01 WO disclosed
US-20140251821-A1 CUSTOM IONIC LIQUID ELECTROLYTES FOR ELECTROLYTIC DECARBOXYLATION CERAMATEC, INC. (US) 2014-09-11 US disclosed
US-8591757-B2 Electrolyte composition and ionic liquid KANEKA CORPORATION (JP) 2013-11-26 US disclosed
US-20100213402-A1 ELECTROLYTE COMPOSITION AND IONIC LIQUID KANEKA CORPORATION (JP) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160254098-A1 METHOD FOR PREPARING IONIC LIQUID HAVING CARBOXYLIC ACID ANION USING MICROREACTOR HCN4, ASIC1, ASIC3 MEN1 1599/4885HSP90AA1 3114/4885KMT2A 1643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.